Edition:
United States

Fennec Pharmaceuticals Inc (FENC.OQ)

FENC.OQ on NASDAQ Stock Exchange Capital Market

13.35USD
20 Apr 2018
Change (% chg)

$-0.22 (-1.62%)
Prev Close
$13.57
Open
$13.51
Day's High
$13.51
Day's Low
$13.29
Volume
6,008
Avg. Vol
11,703
52-wk High
$14.85
52-wk Low
$8.02

Select another date:

Tue, Mar 27 2018

BRIEF-Fennec Pharmaceuticals Receives Breakthrough Therapy Designation By FDA For Pedmark™

* FENNEC PHARMACEUTICALS RECEIVES BREAKTHROUGH THERAPY DESIGNATION BY FDA FOR PEDMARK™

BRIEF-Fennec Says Phase 3 SIOPEL 6 Study Met Primary Endpoint

* FENNEC PROVIDES BUSINESS UPDATE AND ANNOUNCES FISCAL YEAR ENDED DECEMBER 31, 2017 FINANCIAL RESULTS

BRIEF-Fennec Pharmaceuticals Receives Fast Track Designation By FDA For Pedmark

* FENNEC PHARMACEUTICALS RECEIVES FAST TRACK DESIGNATION BY FDA FOR PEDMARK

BRIEF-Fennec Announces Pricing Of Public Offering

* SAYS PUBLIC OFFERING OF 2.35 MILLION COMMON SHARES PRICED AT $8.50PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Fennec Pharmaceuticals Q3 loss per share $0.15‍​

* Fennec provides business update and reports third quarter 2017 results

BRIEF-Fennec pharmaceuticals files for stock shelf of up to $90 mln

* Files for stock shelf of up to $90 million - SEC filing‍​ Source text (http://bit.ly/2h66FIr) Further company coverage:

Select another date: